Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe de Moerloose

Showing results (11-20 of 135) with videos related to

Pageof 14
Sort By:
The Lancet. Neurology|July 10, 2003
Should neurologists measure D-dimer concentrations?Philippe de Moerloose, Françoise Boehlen
Handbook of Clinical Neurology|September 16, 2008
Blood coagulation and fibrinolysis: mechanisms of thrombosisPhilippe de Moerloose, Françoise Boehlen
Thrombosis Research|September 3, 2008
Preventing and treating bleeding complications: new insights into therapeutic optionsPhilippe de Moerloose, Claude Négrier
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 23, 2021
How to implement medical and patient associations in low-income countries: A proposition from the African French Alliance for the Treatment of Haemophilia (AFATH)Thomas Sannié, Philippe de Moerloose,
Human Mutation|February 14, 2007
Mutations in the fibrinogen gene cluster accounting for congenital afibrinogenemia: an update and report of 10 novel mutationsMarguerite Neerman-Arbez, Philippe de Moerloose
Expert Opinion on Biological Therapy|June 14, 2008
Treatment of congenital fibrinogen disordersPhilippe de Moerloose, Marguerite Neerman-Arbez
The American Journal of Medicine|June 5, 2004
Aspirin or clopidogrel for secondary prevention of cardiovascular events: is there a winner?Jean-Michel Gaspoz, Philippe de Moerloose
Seminars in Thrombosis and Hemostasis|July 15, 2009
Congenital fibrinogen disordersPhilippe de Moerloose, Marguerite Neerman-Arbez
Thrombosis Research|November 30, 2004
Agreement of a new whole-blood PT/INR test using capillary samples with plasma INR determinationsFrançoise Boehlen, Guido Reber, Philippe de Moerloose
Seminars in Thrombosis and Hemostasis|September 25, 2008
Technical aspects in laboratory testing for antiphospholipid antibodies: is standardization an impossible dream?Guido Reber, Françoise Boehlen, Philippe de Moerloose
Pageof 14

Showing results (11-20 of 135) with videos related to

Sort By:
Pageof 14
The Lancet. Neurology|July 10, 2003
Should neurologists measure D-dimer concentrations?Philippe de Moerloose, Françoise Boehlen
Handbook of Clinical Neurology|September 16, 2008
Blood coagulation and fibrinolysis: mechanisms of thrombosisPhilippe de Moerloose, Françoise Boehlen
Thrombosis Research|September 3, 2008
Preventing and treating bleeding complications: new insights into therapeutic optionsPhilippe de Moerloose, Claude Négrier
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 23, 2021
How to implement medical and patient associations in low-income countries: A proposition from the African French Alliance for the Treatment of Haemophilia (AFATH)Thomas Sannié, Philippe de Moerloose,
Human Mutation|February 14, 2007
Mutations in the fibrinogen gene cluster accounting for congenital afibrinogenemia: an update and report of 10 novel mutationsMarguerite Neerman-Arbez, Philippe de Moerloose
Expert Opinion on Biological Therapy|June 14, 2008
Treatment of congenital fibrinogen disordersPhilippe de Moerloose, Marguerite Neerman-Arbez
The American Journal of Medicine|June 5, 2004
Aspirin or clopidogrel for secondary prevention of cardiovascular events: is there a winner?Jean-Michel Gaspoz, Philippe de Moerloose
Seminars in Thrombosis and Hemostasis|July 15, 2009
Congenital fibrinogen disordersPhilippe de Moerloose, Marguerite Neerman-Arbez
Thrombosis Research|November 30, 2004
Agreement of a new whole-blood PT/INR test using capillary samples with plasma INR determinationsFrançoise Boehlen, Guido Reber, Philippe de Moerloose
Seminars in Thrombosis and Hemostasis|September 25, 2008
Technical aspects in laboratory testing for antiphospholipid antibodies: is standardization an impossible dream?Guido Reber, Françoise Boehlen, Philippe de Moerloose
Pageof 14